Patient-derived breast cancer xenografts: Molecular characteristics and growth properties

被引:0
|
作者
Giesemann, T. [1 ]
Krumbach, R. [1 ]
Schueler, J. [1 ]
Vuaroqueaux, V.
Hofmann, M. [1 ]
Liu, N. [2 ]
Haegebarth, A. [2 ]
Beckers, T. [1 ]
机构
[1] Oncotest GmbH, Inst Expt Oncol, Freiburg, Germany
[2] Oncotest AG, Mol Diagnost, Riehen, Switzerland
来源
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词
D O I
10.1016/S1359-6349(10)72341-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:198 / 199
页数:2
相关论文
共 50 条
  • [1] Molecular profiling of patient-derived breast cancer xenografts
    Fabien Reyal
    Charlotte Guyader
    Charles Decraene
    Carlo Lucchesi
    Nathalie Auger
    Franck Assayag
    Ludmilla De Plater
    David Gentien
    Marie-France Poupon
    Paul Cottu
    Patricia De Cremoux
    Pierre Gestraud
    Anne Vincent-Salomon
    Jean-Jacques Fontaine
    Sergio Roman-Roman
    Olivier Delattre
    Didier Decaudin
    Elisabetta Marangoni
    Breast Cancer Research, 14
  • [2] Metastasis characteristics of breast cancer patient-derived xenografts
    Alzubi, M.
    Turner, T.
    Sohal, S.
    Olex, A.
    Dozmorov, M.
    Harrell, J. C.
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (02) : 141 - 142
  • [3] Molecular profiling of patient-derived breast cancer xenografts
    Reyal, Fabien
    Guyader, Charlotte
    Decraene, Charles
    Lucchesi, Carlo
    Auger, Nathalie
    Assayag, Franck
    De Plater, Ludmilla
    Gentien, David
    Poupon, Marie-France
    Cottu, Paul
    De Cremoux, Patricia
    Gestraud, Pierre
    Vincent-Salomon, Anne
    Fontaine, Jean-Jacques
    Roman-Roman, Sergio
    Delattre, Olivier
    Decaudin, Didier
    Marangoni, Elisabetta
    BREAST CANCER RESEARCH, 2012, 14 (01):
  • [4] Molecular characterization of a panel of patient-derived breast cancer xenografts
    Giesemann, Torsten
    Krumbach, Rebekka
    Schiller, Julia
    Vuaroqueaux, Vincent
    Hofmann, Michael
    Liu, Ningshu
    Haegebarth, Andrea
    Beckers, Thomas
    Fiebig, Heinz-Herbert
    CANCER RESEARCH, 2010, 70
  • [5] Triple negative breast cancer patient-derived xenografts: Molecular characteristics and sensitivity to emerging therapies
    Evans, K. W.
    Yuca, E.
    Akcakanat, A.
    Scott, S. M.
    Arango, N. Paez
    Zheng, X.
    Chen, K.
    Tapia, C.
    Tarco, E.
    Eterovic, A. K.
    Black, D. M.
    Jennifer, L. K.
    Tripathy, D.
    Mills, G. B.
    Meric-Bernstam, F.
    CANCER RESEARCH, 2017, 77
  • [6] Functional and molecular characteristics of patient-derived xenografts of colon cancer.
    Guo, Jianing M.
    Klingner, Kerstin
    Krumbach, Rebekka
    Maier, Armin
    Naus, Silvia
    Vuaroqueaux, Vincent
    Lamy, Evelyn
    Fiebig, Heiner
    Schueler, Julia B.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [7] Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts)
    Guerrero, Tatiana Hernandez
    Banos, Natalia
    Nevado, Laura del Puerto
    Mahillo-Fernandez, Ignacio
    De-Speville, Bernard Doger
    Calvo, Emiliano
    Wick, Michael
    Garcia-Foncillas, Jesus
    Moreno, Victor
    CANCERS, 2023, 15 (22)
  • [8] The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer
    Lewis, Michael T.
    Caldas, Carlos
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2024, 14 (04):
  • [9] Patient-derived tumour xenografts for breast cancer drug discovery
    Cassidy, John W.
    Batra, Ankita S.
    Greenwood, Wendy
    Bruna, Alejandra
    ENDOCRINE-RELATED CANCER, 2016, 23 (12) : T259 - T270
  • [10] Patient-derived xenografts accurately predict patient response in breast cancer patients
    Stow, Lisa
    Katz, Amanda
    Irie, Hanna
    Port, Elisa
    Stebbing, Justin
    Ciznadija, Daniel
    Davies, Angela
    Paz, Keren
    CANCER RESEARCH, 2015, 75